Adage Capital Management L.P. 13D and 13G filings for EyePoint Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:33 am Purchase |
2024-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
Adage Capital Management L.P. | 5,750,000 8.420% |
1,958,580 (+51.66%) |
Filing |
| 2024-11-12 09:33 am Sale |
2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
Adage Capital Management L.P. | 3,791,420 7.080% |
-1,364,879 (-26.47%) |
Filing |
| 2024-05-01 5:08 pm Unchanged |
2024-04-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
Adage Capital Management L.P. | 5,156,299 9.900% |
0 (Unchanged) |
Filing |
| 2024-04-30 8:53 pm Purchase |
2024-04-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
Adage Capital Management L.P. | 5,156,299 10.350% |
5,156,299 (New Position) |
Filing |